Annual Operating Profit
-$5.75 M
+$780.90 K+11.95%
August 31, 2024
Summary
- As of February 8, 2025, LEXX annual operating income is -$5.75 million, with the most recent change of +$780.90 thousand (+11.95%) on August 31, 2024.
- During the last 3 years, LEXX annual operating profit has fallen by -$66.20 thousand (-1.16%).
- LEXX annual operating profit is now -117310.20% below its all-time high of -$4900.00, reached on October 31, 2012.
Performance
LEXX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$2.69 M
-$487.60 K-22.13%
November 30, 2024
Summary
- As of February 8, 2025, LEXX quarterly operating income is -$2.69 million, with the most recent change of -$487.60 thousand (-22.13%) on November 30, 2024.
- Over the past year, LEXX quarterly operating profit has stayed the same.
- LEXX quarterly operating profit is now -478.12% below its all-time high of $711.60 thousand, reached on October 31, 2007.
Performance
LEXX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$7.30 M
-$1.55 M-26.97%
November 30, 2024
Summary
- As of February 8, 2025, LEXX TTM operating income is -$7.30 million, with the most recent change of -$1.55 million (-26.97%) on November 30, 2024.
- Over the past year, LEXX TTM operating profit has stayed the same.
- LEXX TTM operating profit is now -1485.30% below its all-time high of $527.30 thousand, reached on July 31, 2008.
Performance
LEXX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
LEXX Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.9% | 0.0% | 0.0% |
| 3 y3 years | -1.2% | -58.7% | -15.8% |
| 5 y5 years | -41.7% | -58.7% | -15.8% |
LEXX Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1.2% | +13.1% | -302.8% | at low | -56.6% | +0.2% |
| 5 y | 5-year | -41.7% | +13.1% | -302.8% | at low | -78.6% | +0.2% |
| alltime | all time | <-9999.0% | +13.1% | -478.1% | +21.4% | -1485.3% | +0.2% |
Lexaria Bioscience Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Nov 2024 | - | -$2.69 M(+22.1%) | -$7.30 M(+27.0%) |
| Aug 2024 | -$5.75 M(-12.0%) | -$2.20 M(+26.4%) | -$5.75 M(+23.3%) |
| May 2024 | - | -$1.74 M(+160.9%) | -$4.66 M(-12.4%) |
| Feb 2024 | - | -$668.00 K(-41.4%) | -$5.32 M(-11.0%) |
| Nov 2023 | - | -$1.14 M(+2.2%) | -$5.98 M(-8.5%) |
| Aug 2023 | -$6.53 M(-1.3%) | -$1.11 M(-53.6%) | -$6.53 M(+5.9%) |
| May 2023 | - | -$2.40 M(+81.4%) | -$6.17 M(-0.3%) |
| Feb 2023 | - | -$1.32 M(-21.9%) | -$6.19 M(-2.0%) |
| Nov 2022 | - | -$1.70 M(+126.5%) | -$6.31 M(-4.7%) |
| Aug 2022 | -$6.62 M(+16.4%) | -$748.50 K(-69.0%) | -$6.62 M(-7.7%) |
| May 2022 | - | -$2.42 M(+66.9%) | -$7.17 M(-2.0%) |
| Feb 2022 | - | -$1.45 M(-27.7%) | -$7.32 M(+4.9%) |
| Nov 2021 | - | -$2.00 M(+53.8%) | -$6.98 M(+22.7%) |
| Aug 2021 | -$5.69 M(+37.1%) | -$1.30 M(-49.2%) | -$5.69 M(+6.9%) |
| May 2021 | - | -$2.57 M(+132.4%) | -$5.32 M(+28.8%) |
| Feb 2021 | - | -$1.10 M(+54.9%) | -$4.13 M(+1.0%) |
| Nov 2020 | - | -$713.10 K(-23.7%) | -$4.09 M(-5.1%) |
| Aug 2020 | -$4.15 M(+2.2%) | -$935.10 K(-32.2%) | -$4.31 M(-2.0%) |
| May 2020 | - | -$1.38 M(+29.7%) | -$4.40 M(+4.4%) |
| Feb 2020 | - | -$1.06 M(+13.7%) | -$4.21 M(-2.1%) |
| Nov 2019 | - | -$934.50 K(-8.7%) | -$4.30 M(+6.0%) |
| Aug 2019 | -$4.06 M(-38.5%) | -$1.02 M(-14.1%) | -$4.06 M(-4.8%) |
| May 2019 | - | -$1.19 M(+3.3%) | -$4.26 M(-34.3%) |
| Feb 2019 | - | -$1.15 M(+66.7%) | -$6.49 M(-3.3%) |
| Nov 2018 | - | -$691.80 K(-43.6%) | -$6.72 M(+1.8%) |
| Aug 2018 | -$6.60 M(+255.8%) | -$1.23 M(-64.1%) | -$6.60 M(+9.5%) |
| May 2018 | - | -$3.42 M(+148.5%) | -$6.03 M(+104.4%) |
| Feb 2018 | - | -$1.38 M(+139.4%) | -$2.95 M(+44.9%) |
| Nov 2017 | - | -$575.20 K(-12.2%) | -$2.03 M(+9.7%) |
| Aug 2017 | -$1.85 M(+50.7%) | -$654.80 K(+91.6%) | -$1.85 M(+21.3%) |
| May 2017 | - | -$341.80 K(-26.1%) | -$1.53 M(+6.1%) |
| Feb 2017 | - | -$462.50 K(+16.9%) | -$1.44 M(+17.2%) |
| Nov 2016 | - | -$395.70 K(+20.4%) | -$1.23 M(-0.2%) |
| Aug 2016 | -$1.23 M(-36.2%) | -$328.70 K(+29.4%) | -$1.23 M(-18.7%) |
| May 2016 | - | -$254.10 K(+1.4%) | -$1.51 M(-14.0%) |
| Feb 2016 | - | -$250.50 K(-37.0%) | -$1.76 M(-10.3%) |
| Nov 2015 | - | -$397.70 K(-35.0%) | -$1.96 M(+1.8%) |
| Aug 2015 | -$1.93 M | -$611.60 K(+22.2%) | -$1.93 M(+4.7%) |
| May 2015 | - | -$500.50 K(+10.5%) | -$1.84 M(+4.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Feb 2015 | - | -$453.10 K(+24.8%) | -$1.77 M(+34.4%) |
| Nov 2014 | - | -$363.00 K(-31.0%) | -$1.32 M(-6.1%) |
| Aug 2014 | -$1.27 M(+236.0%) | - | - |
| Jul 2014 | - | -$525.80 K(+22.7%) | -$1.40 M(+55.8%) |
| Apr 2014 | - | -$428.50 K(+410.1%) | -$900.00 K(+91.8%) |
| Jan 2014 | - | -$84.00 K(-76.9%) | -$469.20 K(+24.0%) |
| Oct 2013 | -$378.40 K(+7622.4%) | -$364.00 K(+1448.9%) | -$378.40 K(-522.8%) |
| Jul 2013 | - | -$23.50 K(-1121.7%) | $89.50 K(-61.1%) |
| Apr 2013 | - | $2300.00(-66.2%) | $229.90 K(+242.1%) |
| Jan 2013 | - | $6800.00(-93.5%) | $67.20 K(-1444.0%) |
| Oct 2012 | -$4900.00(-98.1%) | $103.90 K(-11.1%) | -$5000.00(+194.1%) |
| Jul 2012 | - | $116.90 K(-172.9%) | -$1700.00(-99.5%) |
| Apr 2012 | - | -$160.40 K(+145.3%) | -$314.00 K(+55.3%) |
| Jan 2012 | - | -$65.40 K(-161.0%) | -$202.20 K(-3.8%) |
| Oct 2011 | -$259.50 K(-32.6%) | $107.20 K(-154.9%) | -$210.10 K(-44.4%) |
| Jul 2011 | - | -$195.40 K(+302.1%) | -$378.20 K(+94.3%) |
| Apr 2011 | - | -$48.60 K(-33.7%) | -$194.60 K(-14.3%) |
| Jan 2011 | - | -$73.30 K(+20.4%) | -$227.20 K(-41.0%) |
| Oct 2010 | -$385.10 K(-35.1%) | -$60.90 K(+416.1%) | -$385.10 K(-15.4%) |
| Jul 2010 | - | -$11.80 K(-85.5%) | -$455.00 K(-25.4%) |
| Apr 2010 | - | -$81.20 K(-64.9%) | -$609.70 K(-13.2%) |
| Jan 2010 | - | -$231.20 K(+76.8%) | -$702.60 K(+18.4%) |
| Oct 2009 | -$593.50 K(+20.5%) | -$130.80 K(-21.4%) | -$593.50 K(-16.0%) |
| Jul 2009 | - | -$166.50 K(-4.4%) | -$706.40 K(+23.4%) |
| Apr 2009 | - | -$174.10 K(+42.6%) | -$572.30 K(+11.5%) |
| Jan 2009 | - | -$122.10 K(-49.9%) | -$513.50 K(+20.0%) |
| Oct 2008 | -$492.70 K(-53.1%) | -$243.70 K(+652.2%) | -$428.00 K(-181.2%) |
| Jul 2008 | - | -$32.40 K(-71.9%) | $527.30 K(-190.6%) |
| Apr 2008 | - | -$115.30 K(+215.0%) | -$582.20 K(-30.5%) |
| Jan 2008 | - | -$36.60 K(-105.1%) | -$837.60 K(-20.6%) |
| Oct 2007 | -$1.05 M(+396.5%) | $711.60 K(-162.3%) | -$1.06 M(-43.7%) |
| Jul 2007 | - | -$1.14 M(+208.0%) | -$1.87 M(+138.8%) |
| Apr 2007 | - | -$370.70 K(+45.9%) | -$784.90 K(+76.8%) |
| Jan 2007 | - | -$254.10 K(+135.9%) | -$444.00 K(+102.9%) |
| Oct 2006 | -$211.50 K(+502.6%) | -$107.70 K(+105.5%) | -$218.80 K(+96.9%) |
| Jul 2006 | - | -$52.40 K(+75.8%) | -$111.10 K(+89.3%) |
| Apr 2006 | - | -$29.80 K(+3.1%) | -$58.70 K(+103.1%) |
| Jan 2006 | - | -$28.90 K | -$28.90 K |
| Oct 2005 | -$35.10 K | - | - |
FAQ
- What is Lexaria Bioscience annual operating income?
- What is the all time high annual operating profit for Lexaria Bioscience?
- What is Lexaria Bioscience annual operating profit year-on-year change?
- What is Lexaria Bioscience quarterly operating income?
- What is the all time high quarterly operating profit for Lexaria Bioscience?
- What is Lexaria Bioscience quarterly operating profit year-on-year change?
- What is Lexaria Bioscience TTM operating income?
- What is the all time high TTM operating profit for Lexaria Bioscience?
- What is Lexaria Bioscience TTM operating profit year-on-year change?
What is Lexaria Bioscience annual operating income?
The current annual operating profit of LEXX is -$5.75 M
What is the all time high annual operating profit for Lexaria Bioscience?
Lexaria Bioscience all-time high annual operating income is -$4900.00
What is Lexaria Bioscience annual operating profit year-on-year change?
Over the past year, LEXX annual operating income has changed by +$780.90 K (+11.95%)
What is Lexaria Bioscience quarterly operating income?
The current quarterly operating profit of LEXX is -$2.69 M
What is the all time high quarterly operating profit for Lexaria Bioscience?
Lexaria Bioscience all-time high quarterly operating income is $711.60 K
What is Lexaria Bioscience quarterly operating profit year-on-year change?
Over the past year, LEXX quarterly operating income has changed by $0.00 (0.00%)
What is Lexaria Bioscience TTM operating income?
The current TTM operating profit of LEXX is -$7.30 M
What is the all time high TTM operating profit for Lexaria Bioscience?
Lexaria Bioscience all-time high TTM operating income is $527.30 K
What is Lexaria Bioscience TTM operating profit year-on-year change?
Over the past year, LEXX TTM operating income has changed by $0.00 (0.00%)